ÂÜÀòÂÒÂ×

Ulf Staginnus has a diverse and extensive work experience in the pharmaceutical industry. Ulf is currently serving as the VP International Market Access & Pricing at Blueprint Medicines since November 2021. Prior to that, they held the position of Senior Vice President and Head of Global Market Access & Pricing at Ipsen from March 2018 to October 2021. Before Ipsen, Ulf worked at Shire as the VP and Head of Region Europe Value Demonstration & Access from August 2016 to April 2018. Ulf also briefly served as the Head of Market Access & Pricing Oncology, Region Europe within Shire in June and July 2016. Ulf Staginnus has held significant roles at Baxalta, Endocyte, Amgen, Novartis Oncology, Bristol-Myers Squibb, European Health Economics, and Pfizer Pharmaceuticals throughout their career, showcasing their expertise in market access and pricing strategies in the pharmaceutical industry.

Ulf Staginnus completed their undergraduate studies in Economics at the University of Bayreuth from 1990 to 1996, earning a degree of Dipl. Volkswirt.